Janneke van der Kamp's most recent trade in NewAmsterdam Pharma Company NV was a trade of 32,500 Option (right to buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Compan... | Janneke van der Kamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 32,500 | 32,500 | - | - | Option (right to buy) | |
NewAmsterdam Pharma Compan... | Janneke van der Kamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 6,960 | 6,960 | - | - | Ordinary Shares | |
NewAmsterdam Pharma Compan... | Janneke van der Kamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 10,000 | 10,000 | - | - | Option (right to buy) |